Durability of High-Frequency 10-kHz Spinal Cord Stimulation for Painful Diabetic Neuropathy: 18-Month Multicenter Randomized Controlled Trial Results

Friday, May 13, 2022

2:30 PM – 2:50 PM

Location: Learning Lab A - AACE Learning Zone

Submitter(s)

Christian Nasr, MD
Cleveland Clinic
Westlake, Ohio, United States

Disclosure: Exelixis, Inc (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Horizon pharma plc (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Nevro (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Siemens AG (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Contracted Research, Research Grant

PDF Slides

Participants should be aware of the following financial/non-financial relationships:

Christian Nasr, MD: Exelixis, Inc (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Horizon pharma plc (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Nevro (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards); Siemens AG (Individual(s) Involved: Self): Consulting Fees (e.g., advisory boards), Contracted Research, Research Grant